MSB 2.03% $1.45 mesoblast limited

Why has Novartis taken down the MSB media release from their website?, page-24

  1. 5,229 Posts.
    lightbulb Created with Sketch. 584
    it up there still on there website, looks quite professional and detailed. the credits at the end show how many people are envolved.

    Novartis working relationship would be greatly harmed if they pull the media/news release and/or announced they weren't going the away from MSB. the share price and cred of MSB would be smash with $1 a share or less. I don't believe Novartis have that in them ...the would want a fix it solution. Novartis have been hedging their bet in several field alround the world, with the hope one will pay off. Spent heaps, and don't yet know when their spend $ will whither a bit, and look too much like over spend. They have stated and know that cutting edge medicine as we are used to is changing and fast, so they want to be where it is at and or going not what was or is.....that was made very very clear in several interviews with CEO of Novartis.
    they might tweak the deal with us... and seem to be gearing up with MSB on an FDA attack to EUA, (approach- to be polite but think we are past that).
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.